Nicotine Replacement Therapy Market

Nicotine Replacement Therapy Market by Products (Nicotine Replacement Therapy [Inhalers, Sublingual Tablets, Gum, Lozenges, Transdermal Patches, and Others], E-cigarettes, and Heat-not-burn Tobacco Products), Distribution Channels (Offline and Online), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1230
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 176
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global nicotine replacement therapy market size was valued at USD 44.19 billion in 2020 and is estimated to expand at a CAGR of 16.1% during the forecast period, 2021–2028. The growth of the market is attributed to the rising number of people going for nicotine replacement therapy (NRT) and growing technological advancements.
 

Nicotine Replacement Therapy Market Key Takeaways


Growing awareness about ill-effects of smoking is a key factor responsible for driving the market growth. Globally, the number of smokers is increasing tremendously, which exceeded 1 billion people. Owing to government initiatives such as the “affordable care act”, program for awareness about negative impact of smoking, and insurance policies, smokers are choosing smoking cessation therapies to quit the habit. In the US, in 2018, the number of smokers was around 34 million people and out of which 55% people have tried various smoking cessation methods.

No Tobacco Day is celebrated on 31st May every year. The American Lung Association and the Centers for Disease Control and Prevention (CDC) are the two key organizations working towards spreading awareness about serious medical conditions because of smoking. According to National Health Service (NHS), 70% of the lung cancer cases globally are responsible due to smoking. Moreover, smokers are expected to get heat attacks. In the US, around 480,000 people die every year due to diseases related to smoking. The CDC inducts paid national campaign named the Tips From Former Smokers (Tips) for encouraging healthcare providers to convey the effects of smoking to people.

Technological advancements led to increase in the number of people who switches to advanced therapy products. Advancements in heat-not-burn products such as lozenges and flavored chewing gums are projected to propel the adoption of NRT. The COVID-19 situation had effected moderately on the market. For privative measures, various health care organizations including WHO, CDC, and others have initiated programs encouraging smokers to quit smoking as tobacco smoking damages the lungs and make the person susceptible for COVID-19.

Market Trends, Drivers, Restraints, and Opportunities

  • Growing tobacco addiction among youth is increasing that lead to fuel the demand of NTR products. This is expected to boost the market growth during the forecast period.
  • Rising public initiatives taken by several governments and other international organizations involving in anti-smoking campaign are anticipated to fuel the market growth during the forecast period.
  • Increasing incidence of chronic diseases such as lung cancer among smokers is pushing to raise demand for NRT methods. This is a key factor driving the market expansion.
  • Introducing of several innovative NRT products to expand diagnostic and therapy method for smoking cessation are anticipated to propel the market growth.
  • Strict regulation towards import and production of e-cigarettes is a key challenge for the market. Ban on e-cigarettes in some nations such as Mexico, Brazil, Malaysia, and Thailand is expected to impede the market growth.
  • Lower adoption rate of NRT products due to some myths around the therapy such as ineffective, expensive, and side effects is anticipated to hamper the market growth.

Scope of the Report

The report on the global nicotine replacement therapy market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Nicotine Replacement Therapy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Nicotine Replacement Therapy [Inhalers, Sublingual Tablets, Gum, Lozenges, Transdermal Patches, and Others], E-cigarettes, and Heat-not-burn Tobacco Products), and Distribution Channels (Offline and Online)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Philip Morris Products S.A. (Altria Group), British American Tobacco p.l.c., Japan Tobacco, Inc., Imperial Brands, Glenmark, Fertin Pharma, Cipla Inc., Pfizer Inc., and Johnson & Johnson Services, Inc.

 

Market Segment Insights

E-cigarettes segment is projected to hold a key market share
Based on products, the nicotine replacement therapy market is segmented into nicotine replacement therapy, e-cigarettes, and heat-not-burn tobacco products. The nicotine replacement therapy segment is further divided into inhalers, sublingual tablets, gum, lozenges, transdermal patches, and others. The e-cigarettes segment accounted for a key market share, representing more than 50.2% in 2020 and anticipated to expand at a rapid pace in the coming years owing to increasing adoption rate and rising popularity in many countries. In the US, around 3% of adult smokers were using e-cigarettes in 2018. Based on a study in 2019 by Wiley Journal, around 17% of patients were able to quit smoking because of using combination of multiple NRT whereas 14.1% of patients were able to quit due to use of one type of NRT. This report further stated, products with higher nicotine concentration (4mg) were projected to give positive results than products with lower concentration (2mg) NATs.

On the other hand, the heat-not-burn tobacco products segment is anticipated to grow at a significant pace during the forecast period owing to growing product launches. The awareness about heat-not-burn tobacco products among smokers is high and around 25% smokers want to use the products. Currently, in the US, HnB products are used by approximately 0.8% of the adult population, which constitute 2.9% of smokers.

Offline segment is expected to grow at a significant pace
On the basis of distribution channels, the market is segmented into offline and online. The offline segment held for a major revenue share accounting for more than 83.4% of the global market share in 2020. The offline segment includes hospital pharmacy, retail pharmacy, and other stores. The accessibility of NRT products such as gels, e-cigarettes, transdermal patches, heated tobacco products, and gums in the retail market such as Walgreens and Walmart Stores, Inc., have boosted the segment growth. Additionally, emergence of tie-ups of hospitals with these retail stores are expected to propel the segment growth.

On the other hand, the online segment is anticipated to expand at a rapid pace during the forecast period due to multiple advantages such as flexibility, comfort, and convenience for buying medications and tobacco cessation products. Furthermore, heavy discounts offered by online pharmacies are anticipated to boost the segment growth.
 

Nicotine Replacement Therapy Market by Distribution Channels


Asia Pacific is expected to dominate the market
On the basis of regions, the nicotine replacement therapy market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of Asia Pacific held a large revenue share representing more than 40.1% of the global market in 2020 and is projected to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to increase in demand of NRT products, growing market opportunities, and rising competition among key players mainly in Japan.

 However, North America accounted for a significant market share in 2020 owing to increasing diseases related to smoking and rise in favorable initiatives by governments in the region. Moreover, rising adoption of e-cigarette and heat-not-burn tobacco products are anticipated to fuel the regional market growth.
 

Nicotine Replacement Therapy Market by Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nicotine Replacement Therapy Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Nicotine Replacement Therapy Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Nicotine Replacement Therapy Market - Supply Chain
  4.5. Global Nicotine Replacement Therapy Market Forecast
     4.5.1. Nicotine Replacement Therapy Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Nicotine Replacement Therapy Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Nicotine Replacement Therapy Market Absolute $ Opportunity
5. Global Nicotine Replacement Therapy Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Nicotine Replacement Therapy Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Nicotine Replacement Therapy Demand Share Forecast, 2019-2026
6. North America Nicotine Replacement Therapy Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Nicotine Replacement Therapy Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Nicotine Replacement Therapy Demand Share Forecast, 2019-2026
7. Latin America Nicotine Replacement Therapy Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Nicotine Replacement Therapy Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Nicotine Replacement Therapy Demand Share Forecast, 2019-2026
8. Europe Nicotine Replacement Therapy Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Nicotine Replacement Therapy Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Nicotine Replacement Therapy Demand Share Forecast, 2019-2026
9. Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Nicotine Replacement Therapy Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Nicotine Replacement Therapy Demand Share Forecast, 2019-2026
10. Middle East & Africa Nicotine Replacement Therapy Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Nicotine Replacement Therapy Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Nicotine Replacement Therapy Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Nicotine Replacement Therapy Market: Market Share Analysis
  11.2. Nicotine Replacement Therapy Distributors and Customers
  11.3. Nicotine Replacement Therapy Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Philip Morris Products S.A. (Altria Group)
     11.4.2. British American Tobacco p.l.c.
     11.4.3. Japan Tobacco, Inc.
     11.4.4. Imperial Brands
     11.4.5. Glenmark

Segments Covered in the Report
The global nicotine replacement therapy market has been segmented on the basis of

Products

  • Nicotine Replacement Therapy
    • Inhalers
    • Sublingual Tablets
    • Gum
    • Lozenges
    • Transdermal Patches
    • Others
  • E-cigarettes
  • Heat-not-burn Tobacco Products

Distribution Channels

  • Offline
  • Online

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Philip Morris Products S.A. (Altria Group)
  • British American Tobacco p.l.c.
  • Japan Tobacco, Inc.
  • Imperial Brands
  • Glenmark
  • Fertin Pharma
  • Cipla Inc.
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.

Key players competing in the nicotine replacement therapy market include Philip Morris Products S.A. (Altria Group), British American Tobacco p.l.c., Japan Tobacco, Inc., Imperial Brands, Glenmark, Fertin Pharma, Cipla Inc., Pfizer Inc., and Johnson & Johnson Services, Inc. Companies are adopting business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares. For instance, in January 2017, British American Tobacco acquired stakes around 58% of Reynolds American, Inc. and made it wholly-owned subsidiary of the firm.
 

Nicotine Replacement Therapy Market by Key Players

 

Buy Report